ATE242237T1 - Benzimidazolverbindungen zur anwendung als therapeutisch wirksame substanzen, verfahren zur herstellung dieser verbindungen und pharmazeutische zusammensetzungen die diese enthalten - Google Patents

Benzimidazolverbindungen zur anwendung als therapeutisch wirksame substanzen, verfahren zur herstellung dieser verbindungen und pharmazeutische zusammensetzungen die diese enthalten

Info

Publication number
ATE242237T1
ATE242237T1 AT00902282T AT00902282T ATE242237T1 AT E242237 T1 ATE242237 T1 AT E242237T1 AT 00902282 T AT00902282 T AT 00902282T AT 00902282 T AT00902282 T AT 00902282T AT E242237 T1 ATE242237 T1 AT E242237T1
Authority
AT
Austria
Prior art keywords
alkyl
substituted
aryl
compounds
producing
Prior art date
Application number
AT00902282T
Other languages
English (en)
Inventor
Charles Hedgecock
Eric Desarbre
Guido Kurz
Martin Norin
Marguerite Luthman
Hl Cathrin Widerst
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Application granted granted Critical
Publication of ATE242237T1 publication Critical patent/ATE242237T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/02Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT00902282T 1999-01-25 2000-01-24 Benzimidazolverbindungen zur anwendung als therapeutisch wirksame substanzen, verfahren zur herstellung dieser verbindungen und pharmazeutische zusammensetzungen die diese enthalten ATE242237T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9900211A SE9900211D0 (sv) 1999-01-25 1999-01-25 New compounds
PCT/SE2000/000144 WO2000043387A1 (en) 1999-01-25 2000-01-24 New benzimidazole compounds for use as active therapeutic substances, process for the preparation of these compoudns and pharmaceutical compositions comprising them

Publications (1)

Publication Number Publication Date
ATE242237T1 true ATE242237T1 (de) 2003-06-15

Family

ID=20414207

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00902282T ATE242237T1 (de) 1999-01-25 2000-01-24 Benzimidazolverbindungen zur anwendung als therapeutisch wirksame substanzen, verfahren zur herstellung dieser verbindungen und pharmazeutische zusammensetzungen die diese enthalten

Country Status (12)

Country Link
EP (1) EP1155014B1 (de)
JP (1) JP2002535325A (de)
AT (1) ATE242237T1 (de)
AU (1) AU760346B2 (de)
CA (1) CA2359107A1 (de)
DE (1) DE60003158T2 (de)
DK (1) DK1155014T3 (de)
ES (1) ES2202045T3 (de)
NZ (1) NZ512597A (de)
PT (1) PT1155014E (de)
SE (1) SE9900211D0 (de)
WO (1) WO2000043387A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102361857B (zh) * 2008-09-26 2015-09-16 默沙东公司 可用作抗糖尿病剂的环状苯并咪唑衍生物
GB0908394D0 (en) 2009-05-15 2009-06-24 Univ Leuven Kath Novel viral replication inhibitors
GB0913636D0 (en) * 2009-08-05 2009-09-16 Univ Leuven Kath Novel viral replication inhibitors
MX2013005478A (es) 2010-11-15 2013-08-29 Univ Leuven Kath Compuestos heterociclicos condensados antivirales.

Also Published As

Publication number Publication date
AU2340600A (en) 2000-08-07
JP2002535325A (ja) 2002-10-22
ES2202045T3 (es) 2004-04-01
DK1155014T3 (da) 2003-09-29
EP1155014A1 (de) 2001-11-21
SE9900211D0 (sv) 1999-01-25
DE60003158T2 (de) 2003-12-04
CA2359107A1 (en) 2000-07-27
NZ512597A (en) 2003-12-19
PT1155014E (pt) 2003-10-31
AU760346B2 (en) 2003-05-15
EP1155014B1 (de) 2003-06-04
WO2000043387A1 (en) 2000-07-27
DE60003158D1 (de) 2003-07-10

Similar Documents

Publication Publication Date Title
DE602004020332D1 (de) Neue heterozyklische verbindungen, die sich für die behandlung von entzündlichen und allergischen erkrankungen eignen: verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die diese enthalten
AR019626A1 (es) Antagonistas receptores y5 de neuropeptidos.
SE0100567D0 (sv) Compounds
ECSP066314A (es) Derivados piridilo y su uso como agentes terapéuticos
EA200300929A1 (ru) Новые лекарственные композиции на основе антихолинергических средств и ингибиторов pde-iv
ATE387199T1 (de) Neue substanzen und verbindungen als protease- inhibitoren
ATE339406T1 (de) Chinazoline verbindungen als heilmittel
ATE348808T1 (de) Azacyclische verbindungen zur verwendung in der behandlung von mit serotonin verwandten krankheiten
ATE246190T1 (de) Heterozyklische verbindungen, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen die diese enthalten und ihre anwendung in der behandlung von diabetis und verwandten krankheiten
DE60134245D1 (de) (5-(2-hydroxy-4-chlorbenzoyl)valeriansäure und deren salze, und zusammensetzungen zur zuführung von wirkstoffen, die diese verbindungen enthalten
RU2007106180A (ru) Производные индола, индазола или индолина
AR039190A1 (es) Derivados de benzofurano, composicion farmaceutica y medicamento que comprende el compuesto
DE602004017894D1 (de) Biphenylderivate, die sich als rar-rezeptor-aktivierende liganden eignen, verfahren zu deren herstellung und deren verwendung in der humanmedizin und in kosmetika
BR9709858A (pt) Composto composição farmacêutica uso do composto e processos para tratamento de doenças do sistema endocrinólogico para fabricação de um medicamento específico para ser usado no tratamento de doenças do sistema endocrinológico e para preparação de um composto
DE602004002394D1 (de) (3-ä3-'(2,4-BIS-TRIFLUORMETHYL-BENZYL)-(5-ETHYL-PYRIMIDIN-2-YL)-AMINOÜ-PROPOXYü-PHENYL)-ESSIGSÄURE UND VERWANDTE VERBINDUNGEN ALS MODULATOREN VON PPARS UND VERFAHREN ZUR BEHANDLUNG VON STOFFWECHSELSTÖRUNGEN
ATE369348T1 (de) Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie
ATE242237T1 (de) Benzimidazolverbindungen zur anwendung als therapeutisch wirksame substanzen, verfahren zur herstellung dieser verbindungen und pharmazeutische zusammensetzungen die diese enthalten
EA200401303A1 (ru) Лекарственные средства, содержащие стероиды и новое антихолинергическое средство
AR039391A1 (es) Compuesto de ciclopenteno, composicion farmaceutica que lo comprende y su uso para la fabricacion de un medicamento
DE60134735D1 (de) Neue neurokinin-antagonisten zum gebrauch als arzneimittel
DE68917937D1 (de) Verbindungen mit magensäureinhibitorwirkung und verfahren zur herstellung.
DE60015791D1 (de) Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen
EA200600377A1 (ru) Новая композиция
ATE384066T1 (de) Thieno-pyrrole verbindungen als antagonisten der gonadotropin-freisetzenden hormonrezeptoren
DE60114597D1 (de) Naphthamid-neurokinin antagonisten zur verwendung als medikamente

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1155014

Country of ref document: EP

REN Ceased due to non-payment of the annual fee